Tweenvest Stocks

Universal Ibogaine Inc. (TSXV: IBO)

Health Care · Health Care Providers & Services · CA

CA$—

— today · — 1Y

Universal Ibogaine Inc. (TSXV: IBO) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $1.14M.

trading between 0.01 and 0.05.

Tweenvest scores Universal Ibogaine Inc. across four factors: quality 21/100, value 62/100. Its strongest factor is value.

IBO price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.14M
Revenue (TTM)
$1.49M
P/E
—
EPS
-0.01
Dividend yield
—
Beta (5Y)
4.27
52-week high
CA$0.05
52-week low
CA$0.01
Avg volume (3M)
—
Shares outstanding
312.86M
Employees
—
Next earnings
—

About Universal Ibogaine Inc.

Universal Ibogaine Inc. is a life sciences enterprise that focuses on creating, obtaining, and managing addiction treatment centers throughout Canada. The company is also actively involved in scheduled clinical trials, researching the efficacy of ibogaine as a treatment for addiction. Its operations are directed from its head office in Calgary, Canada.

ISIN
CA91360F1099
Listed since
Jun 22, 2017
Exchange
TSX Venture Exchange
Currency
CAD
CompanyMarket capPriceDay
Acro Biomedical Co., Ltd.OTCPK: ACBM$1.56M$——
Virax Biolabs Group LimitedNasdaqCM: VRAX$1.49M$1.870.00%
Medical Marijuana, Inc.OTCPK: MJNA$1.39M$0.00-50.00%
Global Longlife Hospital and Research LimitedBSE: 543520$1.36MRs12.52+3.05%
Arzneiwerk AG VIDADB: TLIK$1.13M€0.16+33.88%
Family Care Hospitals LimitedBSE: 516110$1.11MRs1.98+12.50%
Dipna Pharmachem LimitedBSE: 543594$1.07MRs3.95-4.82%
PHSC plcAIM: PHSC$1.05M£0.080.00%

Browse every Health Care Providers & Services company →

Figures last refreshed Oct 11, 2026.